UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 163

Sortiert nach

Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus

Gastroenterology (New York, N.Y. 1943), 2015-05, Vol.148 (5), p.1035-1058.e3

2015

Link zum Volltext

Verfügbarkeit prüfen

Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives

Gastroenterology (New York, N.Y. 1943), 2023-09, Vol.165 (3), p.670-681

2023

Link zum Volltext

Verfügbarkeit prüfen

Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression

Clinical gastroenterology and hepatology, 2007, Vol.5 (1), p.103-110

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus

Inflammatory bowel diseases, 2019-01, Vol.25 (1), p.1-13

2019

Link zum Volltext

Verfügbarkeit prüfen

Environmental Factors Associated with Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project

Clinical gastroenterology and hepatology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: The patient perspective

Canadian journal of gastroenterology & hepatology, 2015-08, Vol.29 (6), p.294-296

2015

Link zum Volltext

Verfügbarkeit prüfen

Has the Time Come to Say Goodbye to Therapeutic Drug Monitoring As We Know It?

Gastroenterology (New York, N.Y. 1943), 2022-06, Vol.162 (7), p.1831-1832

2022

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Treatment Response in Crohn’s Disease Patients Using Contrast Enhanced Ultrasound: A Pilot Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S643-S643

2017

Link zum Volltext

Verfügbarkeit prüfen

Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects

BMC medical genetics, 2020-10, Vol.21 (1), p.1-204, Article 204

2020

Link zum Volltext

Verfügbarkeit prüfen

Ulcerative Colitis Patients on Vedolizumab Lacking Response at Induction Phase Continue to Improve Over the First 6 Months of Treatment

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S400-S401

2017

Link zum Volltext

Verfügbarkeit prüfen

Characterizing the Post-Transfer Period Amongst Patients with Pediatric Onset IBD: The Impact of Academic vs. Community Adult Care on Emergent Health Resource Utilization

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S980-S980

2017

Link zum Volltext

Verfügbarkeit prüfen

Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2018-07, Vol.24 (8), p.1808-1814

2018

Link zum Volltext

Verfügbarkeit prüfen

Infliximab for ulcerative colitis following liver transplantation

European journal of gastroenterology & hepatology, 2007-03, Vol.19 (3), p.277-280

2007

Link zum Volltext

Verfügbarkeit prüfen

Persistent Symptoms, CRP Elevation and Treatment Changes Over Time in Crohn's Disease Patients are Associated with Bowel Damage Progression as Expressed by Deterioration of Lemann Index Score

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S784-S784

2017

Link zum Volltext

Verfügbarkeit prüfen

Microbial Composition in IBD May Influence Clinical Symptoms Independent of Endoscopic Activity

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S193-S194

2017

Link zum Volltext

Verfügbarkeit prüfen

Microbiome Composition is Altered in Patients with IBD Independent of Endoscopic Activity

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S991-S991

2017

Link zum Volltext

Verfügbarkeit prüfen

Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2022-11, Vol.163 (5), p.1364-1376.e10

2022

Link zum Volltext

Verfügbarkeit prüfen

Persistent Diarrhea in Patients With Crohn’s Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis

Clinical gastroenterology and hepatology, 2021-02, Vol.19 (2), p.296-304.e3

2021

Link zum Volltext

Verfügbarkeit prüfen

Defining the Optimal Response Criteria for the Crohn's Disease Activity Index for Induction Studies in Patients With Mildly to Moderately Active Crohn's Disease

The American journal of gastroenterology, 2008-12, Vol.103 (12), p.3123-3131

2008

Link zum Volltext

Verfügbarkeit prüfen

An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI

Clinical gastroenterology and hepatology, 2021-12, Vol.19 (12), p.2524-2531

2021

Link zum Volltext

Verfügbarkeit prüfen

The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn’s Disease

Journal of Crohn's and colitis, 2018-04, Vol.12 (4), p.458-464

2018

Link zum Volltext

Verfügbarkeit prüfen

Mathematical weighting of a clinimetric index (Pediatric Ulcerative Colitis Activity Index) was superior to the judgmental approach

Journal of clinical epidemiology, 2009-07, Vol.62 (7), p.738-744

2009

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic therapy for Crohn's disease: a review

Canadian journal of gastroenterology, 2006-10, Vol.20 (10), p.651

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 163

Suche als RSS-Feed

Aktive Filter

ThemaMale

ThemaYoung Adult

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(141)

Publikationsform

Artikel
(163)

Sprache

Englisch
(163)
Japanisch
(8)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives

Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus

Environmental Factors Associated with Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project

Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: The patient perspective

Has the Time Come to Say Goodbye to Therapeutic Drug Monitoring As We Know It?

Prediction of Treatment Response in Crohn’s Disease Patients Using Contrast Enhanced Ultrasound: A Pilot Study

Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects

Ulcerative Colitis Patients on Vedolizumab Lacking Response at Induction Phase Continue to Improve Over the First 6 Months of Treatment

Characterizing the Post-Transfer Period Amongst Patients with Pediatric Onset IBD: The Impact of Academic vs. Community Adult Care on Emergent Health Resource Utilization

Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease

Infliximab for ulcerative colitis following liver transplantation

Persistent Symptoms, CRP Elevation and Treatment Changes Over Time in Crohn's Disease Patients are Associated with Bowel Damage Progression as Expressed by Deterioration of Lemann Index Score

Microbial Composition in IBD May Influence Clinical Symptoms Independent of Endoscopic Activity

Microbiome Composition is Altered in Patients with IBD Independent of Endoscopic Activity

Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease

Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease

Persistent Diarrhea in Patients With Crohn’s Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis

Defining the Optimal Response Criteria for the Crohn's Disease Activity Index for Induction Studies in Patients With Mildly to Moderately Active Crohn's Disease

An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI

The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn’s Disease

Mathematical weighting of a clinimetric index (Pediatric Ulcerative Colitis Activity Index) was superior to the judgmental approach

Antibiotic therapy for Crohn's disease: a review

Aktive Filter

Suchergebnisse filtern